¿Vacuna para la nueva enfermedad por COVID en 2025?
Sí
$10,256 Vol.
$10,256 Vol.
Dec 31, 2025
Reglas
On February 21, a bat coronavirus that has the capacity to spread to humans, known as HKU5-CoV-2, was reportedly discovered (See: https://www.aa.com.tr/en/asia-pacific/china-discovers-new-bat-coronavirus-that-poses-risk-of-animal-to-human-transmission/3489013)
This market will resolve to "Yes" if any vaccine intended for humans and inoculating against HKU5-CoV-2 receives full FDA approval between February 20, and December 31, 2025, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be information from the FDA, including their official list of approved vaccines (https://www.fda.gov/vaccines-blood-biologics/vaccines/vaccines-licensed-use-united-states).
This market will resolve to "Yes" if any vaccine intended for humans and inoculating against HKU5-CoV-2 receives full FDA approval between February 20, and December 31, 2025, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be information from the FDA, including their official list of approved vaccines (https://www.fda.gov/vaccines-blood-biologics/vaccines/vaccines-licensed-use-united-states).
Creado en: Feb 21, 2025, 4:48 PM ET
Volumen
$10,256Fecha de finalización
Dec 31, 2025Creado en
Feb 21, 2025, 4:48 PM ETResolver
0x6A9D22261...Resultado propuesto: No
Sin disputa
Resultado final: No
¿Vacuna para la nueva enfermedad por COVID en 2025?
Sí
$10,256 Vol.
$10,256 Vol.
Dec 31, 2025
Acerca de
On February 21, a bat coronavirus that has the capacity to spread to humans, known as HKU5-CoV-2, was reportedly discovered (See: https://www.aa.com.tr/en/asia-pacific/china-discovers-new-bat-coronavirus-that-poses-risk-of-animal-to-human-transmission/3489013)
This market will resolve to "Yes" if any vaccine intended for humans and inoculating against HKU5-CoV-2 receives full FDA approval between February 20, and December 31, 2025, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be information from the FDA, including their official list of approved vaccines (https://www.fda.gov/vaccines-blood-biologics/vaccines/vaccines-licensed-use-united-states).
This market will resolve to "Yes" if any vaccine intended for humans and inoculating against HKU5-CoV-2 receives full FDA approval between February 20, and December 31, 2025, 11:59 PM ET. Otherwise, this market will resolve to "No".
The primary resolution source for this market will be information from the FDA, including their official list of approved vaccines (https://www.fda.gov/vaccines-blood-biologics/vaccines/vaccines-licensed-use-united-states).
Volumen
$10,256Fecha de finalización
Dec 31, 2025Creado en
Feb 21, 2025, 4:48 PM ETResolver
0x6A9D22261...Resultado propuesto: No
Sin disputa
Resultado final: No
Ten cuidado con los enlaces externos.
Ten cuidado con los enlaces externos.

Ten cuidado con los enlaces externos.
Ten cuidado con los enlaces externos.